Crossmark

First report of B-lymphoblastic leukemia harboring LRRFIP1::FGFR1 fusion: expanding the clinical spectrum of myeloid/lymphoid neoplasms with tyrosine kinase gene fusions

Crossref DOI link: https://doi.org/10.1007/s00277-025-06481-0

Published Online: 2025-06-30

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Xue

Ren, Yuyue

Jin, Yinglan

Li, Xiaoyun

Ma, Xiaoli

Cao, Panxiang

Zhang, Yang

Wang, Fang

Liu, Hongxing

Wang, Wei
License Information

Text and Data Mining valid from 2025-06-30

Version of Record valid from 2025-06-30
More Information

Article History

Received: 13 May 2025

Accepted: 19 June 2025

First Online: 30 June 2025

Declarations

:

: Samples were obtained in accordance with the principles of the Declaration of Helsinki and the Chinese legislation for the protection of personal data and research on human samples. The study was approved by the Institutional Review Board and Ethical Committee of The 2nd Affiliated Hospital of Harbin Medical University. Informed consent was obtained from the patient.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below